CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma

被引：11
|
作者：
Alcázar, JL [1 ]
Miranda, D [1 ]
Unanue, A [1 ]
Novoa, E [1 ]
Alemán, S [1 ]
Madariaga, L [1 ]
机构：
[1] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Obstet & Gynecol, E-31080 Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2004年 / 84卷 / 02期
关键词：
CA-125; optimal cytoreduction; advanced ovarian cancer;
D O I：
10.1016/j.ijgo.2003.10.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal, and peritoneal carcinoma
    Zivanovic, O.
    Chi, D. S.
    Eisenhauer, E. L.
    Sonoda, Y.
    Levine, D. A.
    Brown, C. L.
    Barakat, R. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] CA-125, A MARKER OF OVARIAN EPITHELIAL TUMORS
    RUIBAL, A
    MEDICINA CLINICA, 1988, 91 (02): : 54 - 57
  • [23] A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma
    Chi, Dennis S.
    Zivanovic, Oliver
    Palayekar, Meena J.
    Elsenhauer, Eric L.
    Abu-Rustum, Nadeern R.
    Sonoda, Yukio
    Levine, Douglas A.
    Leltao, Manio M.
    Brown, Carol L.
    Barakat, Richard R.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 6 - 10
  • [24] PREDICTIVE VALUE OF CA-125 LEVELS IN ADVANCED OVARIAN-CANCER
    PATSNER, B
    DAY, TG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (02) : 440 - 441
  • [25] CA-125 level preoperative assessment in early and advanced ovarian carcinoma
    Raspollini, Maria Rosaria
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 356 - 357
  • [26] The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
    G. N. A. Winarno
    Y. M. Hidayat
    S. Soetopo
    S. R. Krisnadi
    M. D. L. Tobing
    S. Rauf
    BMC Research Notes, 13
  • [27] The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
    Winarno, G. N. A.
    Hidayat, Y. M.
    Soetopo, S.
    Krisnadi, S. R.
    Tobing, M. D. L.
    Rauf, S.
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [28] Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma
    Tebes, Stephen J.
    Sayer, Robyn A.
    Palmer, James M.
    Tebes, Christine C.
    Martino, Martin A.
    Hoffman, Mitchel S.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (03) : 482 - 487
  • [29] ELEVATED SERUM CA-125 LEVELS IN PATIENTS WITH OVARIAN FIBROTHECOMAS
    SCHNEIDER, J
    AVILA, M
    BARRENETXEA, G
    MONTOYA, F
    RODRIGUEZESCUDERO, FJ
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) : 481 - 481
  • [30] PREOPERATIVE EVALUATION OF SERUM CA-125 LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN-CANCER
    EINHORN, N
    BAST, RC
    KNAPP, RC
    TJERNBERG, B
    ZURAWSKI, VR
    OBSTETRICS AND GYNECOLOGY, 1986, 67 (03): : 414 - 416
12345